חזרה לתוצאות החיפוש

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS) · Dermatomyositis (DM) · Immune-mediated Necrotizing Myopathy (IMNM) · Immune Thrombocytopenia (ITP)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University of California-Irvine, Orange, California, United States

  • Johns Hopkins University, Baltimore, Maryland, United States

  • Northwell Health, LLC PRIME, Lake Success, New York, United States

  • Hospital for Special Surgery, New York, New York, United States

  • Universtity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

  • Ohio State University, Columbus, Ohio, United States

  • Oregon Health & Science University, Portland, Oregon, United States

  • University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States

  • Amarillo Center for Clinical Research, Amarillo, Texas, United States

  • Austin Neuromuscular Center, Austin, Texas, United States

  • Nerve and Muscle Center of Texas, Houston, Texas, United States

  • Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

  • Westmead Hospital, Sydney, New South Wales, Australia

  • Campbelltown Public Hospital, Sydney, New South Wales, Australia

  • The Alfred Hospital, Melbourne, Victoria, Australia

  • Box Hill Hospital, Melbourne, Victoria, Australia

  • AKH - Medizinische Universitaet Wien, Abteilung fuer Klinische Pharmakologie, Vienna, Austria

  • Diagnostic Consultation Center CONVEX EOOD, Sofia, Sofia City Province, Bulgaria

  • "SHATHD" EAD Sofia, Sofia, Sofia City Province, Bulgaria

  • UMHAT "Prof. Dr. St. Kirkovich", AD, Stara Zagora, Stara Zagora Province, Bulgaria

  • University of Alberta Hospital - Department of Anesthesiology and Pain Medicine, Edmonton, Alberta, Canada

  • University of Alberta Hospital - Dermatology, Edmonton, Alberta, Canada

  • The Royal Institution for the Advancement of Learning/McGill University, Montreal, Quebec, Canada

  • Centre de Rhumatologie de l'Est du Quebec, Rimouski, Quebec, Canada

  • DIEX Recherche Sherbrooke Inc., Sherbrooke, Quebec, Canada

  • Clinical Hospital Center "Sestre Milosrdnice", Zagreb, City of Zagreb, Croatia

  • University hospital centre Zagreb, Zagreb, City of Zagreb, Croatia

  • Specialty Hospital Medico, Rijeka, Primorje-Gorski Kotar County, Croatia

  • Sanatorium Profesora Arenbergera, Prague, Prague, Czechia

  • Hopital Lapeyronie,Service d'Immuno Rhumatologie, Montpellier, Occitanie, France

  • AP-HP Hôpital Universitaire Pitié Salpêtrière, Paris, Île-de-France Region, France

  • Universitaetsklinikum Tuebingen, Tübingen, Baden-Wurttemberg, Germany

  • Universitaetsklinikum Erlangen, Erlangen, Bavaria, Germany

  • Universitaetsklinikum Carl Gustav Carus TU Dresden, Klinik und Poliklinik f. Dermatologie, Sachsen, Bundesländer, Germany

  • Universitaetsmedizin Goettingen, Göttingen, Göttingen District, Germany

  • Universitaetsklinikum Schleswig Holstein - Campus Luebeck, Klinik f Dermatologie, Allergologie u Venerologie, Lübeck, Schleswig-Holstein, Germany

  • Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, Csongrád-Csanád County, Hungary

  • Semmelweis Egyetem, Budapest, Hungary

  • IRCCS Istituto Scientifico Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" - IRST, Meldola, Forlì-Cesena Province, Italy

  • Istituto Clinico Humanitas, Milan, Milan Province, Italy

  • Ospedale San Giovanni Bosco, Torino, Turin Province, Italy

  • Hokkaido University Hospital, Sapporo, Hokkaido, Japan

  • Tohoku University Hospital, Sendai, Miyagi, Japan

  • Kindai University Hospital, Sayama, Osaka, Japan

  • Osaka University Hospital, Suita, Osaka, Japan

  • Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan

  • National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan

  • Toho University Omori Medical Center, Ōta-ku, Tokyo, Japan

  • Okayama University Hospital, Okayama, Japan

  • University Medical Centre Groningen UMCG, Groningen, Groningen Province, Netherlands

  • UMC Utrecht, Utrecht, Utrecht Province, Netherlands

  • Sorlandet sykehus Kristiansand, Kristiansand, Agder County, Norway

  • Stavanger Universitetssjukehus, Stavanger, Rogaland County, Norway

  • Institute Reumatologii I'm. Eleonory Reicher, Warsaw, Masovian Voivodeship, Poland

  • Centro Clinico Academico Braga, Braga, Braga District, Portugal

  • Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E., Vila Nova de Gaia, Porto District, Portugal

  • Centrul Medical Monza SRL, Bucharest, Bucharest Municipality, Romania

  • Oncology Institute Prof. Dr. Ion Chiricuta I.O.C.N., Cluj-Napoca, Cluj, Romania

  • Clinica Universidad de Navarra, Pamplona, Community of Madrid & Navarre, Spain

  • Hospital Universitario Ramon y Cajal, Servicio de Reumatologia, Madrid, Madrid, Spain

  • Hospital Universitario 12 de October, Madrid, Madrid, Spain

  • Hospital Universitari Vall d'Hebron, Internal Medicine Dept., Barcelona, Province of Barcelona and Catalonia, Spain

  • Hospital Universitario Reina Sofia, Córdoba, Province Of Córdoba, Spain

  • Hospital Universitario Virgen del Rocio, Seville, Province Of Seville, Spain

  • Hospital Universitari i Politecnic La Fe, Valencia, Valencia, Spain

  • National Taiwan University Hospital, Taipei, Taiwan

  • Taichung Veterans General Hospital, Taipei, Taiwan

  • Dr. Abdurrahman Yurtaslan Oncology Teaching and Research Hospital, Ankara, Ankara, Turkey (Türkiye)

  • Istanbul University Istanbul Medical Faculty, Istanbul, Istanbul, Turkey (Türkiye)

מובילי המחקר

  • Sponsor Chugai Pharmaceutical Co.Ltd

    Study Director

    clinical-trials@chugai-pharm.co.jp

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)